Upgrade to SI Premium - Free Trial

GeneDx Holdings (WGS)

88.40 -0.08 (0.09%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/3/26)

Latest Headlines

Form 4 GeneDx Holdings Corp. For: Sep 16 Filed by: Stueland Katherine September 18, 2026 4:43 PM - SEC Filing Form 4 GeneDx Holdings Corp. For: Sep 16 Filed by: Feeley Kevin September 18, 2026 4:39 PM - SEC Filing Form 4 GeneDx Holdings Corp. For: Sep 17 Filed by: Fuchs Thomas September 18, 2026 4:37 PM - SEC Filing Form 4 GeneDx Holdings Corp. For: Sep 09 Filed by: Stueland Katherine September 11, 2026 4:14 PM - SEC Filing Form 4 GeneDx Holdings Corp. For: Sep 09 Filed by: Feeley Kevin September 11, 2026 4:11 PM - SEC Filing Study finds rapid genome sequencing boosts pediatric diagnoses at Seattle Children's August 24, 2026 8:34 AM - StreetInsider GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s August 24, 2026 8:30 AM - BizWire Form SCHEDULE 13G GeneDx Holdings Corp. Filed by: GOLDMAN SACHS GROUP INC August 11, 2026 7:30 PM - SEC Filing GeneDx launches online exome testing access for pediatric patients August 11, 2026 8:31 AM - StreetInsider GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy August 11, 2026 8:30 AM - BizWire Form SCHEDULE 13G/A GeneDx Holdings Corp. Filed by: ARK Investment Management LLC August 7, 2026 1:58 PM - SEC Filing GeneDx to Participate in Upcoming Investor Conferences August 6, 2026 4:05 PM - BizWire GeneDx (WGS) PT Raised to $90 at Canaccord August 4, 2026 6:44 AM - StreetInsider After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR August 3, 2026 4:36 PM - StreetInsider GeneDx Holdings (WGS) Misses Q2 EPS by 14c, Offers Guidance August 3, 2026 4:22 PM - StreetInsider Form 10-Q GeneDx Holdings Corp. For: Jun 30 August 3, 2026 4:20 PM - SEC Filing Form 8-K GeneDx Holdings Corp. For: Aug 03 August 3, 2026 4:15 PM - SEC Filing GeneDx Reports Second Quarter 2026 Financial Results August 3, 2026 4:05 PM - BizWire GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 31, 2026 1:56 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 29, 2026 4:55 PM - StreetInsider Form SCHEDULE 13G GeneDx Holdings Corp. Filed by: BlackRock, Inc. July 28, 2026 4:47 PM - SEC Filing GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 27, 2026 2:47 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 24, 2026 5:23 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 22, 2026 4:54 PM - StreetInsider Form 25-NSE GeneDx Holdings Corp. Filed by: Nasdaq Stock Market LLC July 21, 2026 4:08 PM - SEC Filing GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 20, 2026 3:48 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 17, 2026 4:31 PM - StreetInsider GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026 July 16, 2026 4:05 PM - BizWire GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 8, 2026 10:07 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 7, 2026 3:13 PM - StreetInsider Important Notice to Long-Term Shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA); GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); and New Era Energy & Digital, Inc. (NASDAQ: NUAI) (F July 7, 2026 8:19 AM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 6, 2026 2:14 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 2, 2026 5:39 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC July 1, 2026 5:38 PM - StreetInsider Form 4 GeneDx Holdings Corp. For: Jun 29 Filed by: GARDNER MARK A July 1, 2026 4:11 PM - SEC Filing Important Notice to Long-Term Shareholders of GeneDx Holdings Corp. (NASDAQ: WGS); Navan, Inc. (NASDAQ: NAVN); New Era Energy & Digital, Inc. (NASDAQ: NUAI) (FKA New Era Helium (NASDAQ: NEHC)); and Ve July 1, 2026 8:31 AM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC June 30, 2026 4:03 PM - StreetInsider GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC June 29, 2026 4:00 PM - StreetInsider Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Navan, Inc. (NASDAQ: NAVN): Grabar Law Office is Inve June 29, 2026 8:53 AM - StreetInsider GeneDx (WGS) PT Raised to $74 at Guggenheim June 29, 2026 6:55 AM - StreetInsider Full Article List